CCM2 and cerebral cavernous malformation: The mutation detection rate of current molecular genetic CCM1/CCM2/CCM3 analyses is 87–98% for families with two or more CCM patients and up to 57–75% for index cases with multiple CCMs but a negative family history (4–6).